BiotechTube
Home/Pipeline/ArteraAI Breast Cancer Test

ArteraAI Breast Cancer Test

Breast Cancer

Development/ValidationActive

Key Facts

Indication
Breast Cancer
Phase
Development/Validation
Status
Active
Company
Artera

About Artera

Artera is a commercial-stage diagnostics company using multimodal AI to personalize cancer therapy, starting with prostate cancer. Its FDA-authorized ArteraAI Prostate Test helps identify patients with biochemical recurrence who may benefit from intensified salvage therapy, guiding treatment decisions for clinicians. The company has established significant clinical validation, guideline inclusion, and commercial traction with over 400 institutions. Artera is expanding its platform into new cancer types, including breast cancer, positioning itself at the intersection of AI, digital pathology, and precision oncology.

View full company profile

Therapeutic Areas

OncologyProstate CancerBreast Cancer

Other Breast Cancer Drugs

DrugCompanyPhase
Antifibrotic Therapy ProgramMeCo DiagnosticsPre-clinical
inPROBE for HER2SDS OpticClinical Investigation
ACT‑BC1AnthrocellPreclinical
APA-1000 Breast Thermotherapy SystemMedifocusPhase III
Early‑Detection Breast Cancer ScreeningKarkinos HealthcareMarket
Unnamed Breast Cancer ProgramClick TherapeuticsPilot/Phase 2
Lerociclib (Lerocliclib)Chemogenics BioPharmaPhase 3
AT-017Asieris PharmaceuticalsNot Specified
CDK2 inhibitorAcelleraPre-clinical
NP-G2-044Novita PharmaceuticalsPhase 2a
Maveropepimut-S (MVP-S)BioVaxysClinical Evaluation
Cannabics® BRST-33CNBX PharmaceuticalsDiscovery